Open an account

Direxion mRNA ETF

MSGR · ETF

$177.61−$12.39 (−6.52%)TodayMarket closed ·
Prev close $190.00

About MSGR

MSGR was created on 2021-12-09 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 3.02m in AUM and 24 holdings. MSGR tracks a market-cap-weighted index of companies from the US, Canada, and Europe that contribute to the development and application of messenger RNA (mRNA) technology.

Issuer
Direxion
Tracks
BITA Messenger RNA Technology Index - Benchmark TR Net
Expense ratio
0.65%
Assets under management
$3.02M
Inception
Dec 9, 2021
Asset class
Equity
Website
direxion.com

MSGR key statistics

Average volume
393.51K
Volume
393.51K
Open price
$176.00
High today
$194.15
Low today
$176.00
52 Week high
$194.15
52 Week low
$176.00

Direxion mRNA ETF (MSGR) at a glance

Direxion mRNA ETF (MSGR) last traded at $177.61.

Today the fund has traded between $176.00 and $194.15. The current price is 0.9% above the day's low and 8.5% below its high.

Volume so far is 393.51K shares, in line with the average of 393.51K shares a day.

Over the past year Direxion mRNA ETF has ranged from $176.00 to $194.15, and now sits 9% of the way up that range.

MSGR news

  • Press releaseBusiness Wire

    MSG Rangers Becomes New Public Company

  • Press releasePRNewswire

    MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.